Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/17251
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis |
Author: | Dodd, J. Crowther, C. Cincotta, R. Flenady, V. Robinson, J. |
Citation: | Acta Obstetricia et Gynecologica Scandinavica, 2005; 84(6):526-533 |
Publisher: | Munksgaard Int Publ Ltd |
Issue Date: | 2005 |
ISSN: | 0001-6349 1600-0412 |
Statement of Responsibility: | Jodie M. Dodd, Caroline A. Crowther, Robert Cincotta, Vicki Flenady, Jeffrey S. Robinson |
Abstract: | <h4>Aim</h4>The aim of this study is to assess the role of progesterone in preterm birth prevention.<h4>Methods</h4>A MEDLINE search (from 1966 to the present; date of last search January 2005) was performed - using the key words progesterone, pregnancy, preterm birth, preterm labor, and randomized, controlled trial - in order to identify randomized, controlled trials in which progesterone (either intramuscular or vaginal administration) was compared with placebo or no treatment. Data were extracted and a meta-analysis was performed.<h4>Results</h4>Seven randomized, controlled trials were identified. Women who received progesterone were statistically significantly less likely to give birth before 37 weeks (seven studies, 1020 women, RR = 0.58, 95% CI = 0.48-0.70), to have an infant with birth weight of < or =2.5 kg (six studies, 872 infants, RR = 0.62, 95% CI = 0.49-0.78), or to have an infant diagnosed with intraventricular hemorrhage (one study, 458 infants, RR = 0.25, 95% CI = 0.08-0.82).<h4>Conclusions</h4>For progesterone supplementation to be advocated for women at the risk of preterm birth, the prolongation of gestation demonstrated in this meta-analysis must translate into improved infant outcomes, including a reduction in mortality. There is currently insufficient information to allow recommendations regarding the optimal dose, route, and timing of administration of progesterone supplementation. |
Keywords: | Humans Birth Weight Progesterone Tocolytic Agents Administration, Intravaginal Gestational Age Pregnancy Infant, Newborn Female Obstetric Labor, Premature Randomized Controlled Trials as Topic |
Description: | The definitive version is available at www.blackwell-synergy.com |
DOI: | 10.1111/j.0001-6349.2005.00835.x |
Published version: | http://www.blackwell-synergy.com/doi/abs/10.1111/j.0001-6349.2005.00835.x |
Appears in Collections: | Aurora harvest 2 Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.